Logo image of HYFT

MINDWALK HOLDINGS CORP (HYFT) Stock Fundamental Analysis

USA - NASDAQ:HYFT - CA45257F2008 - Common Stock

1.71 USD
-0.09 (-5%)
Last: 10/15/2025, 8:00:02 PM
1.77 USD
+0.06 (+3.51%)
After Hours: 10/15/2025, 8:00:02 PM
Fundamental Rating

2

Overall HYFT gets a fundamental rating of 2 out of 10. We evaluated HYFT against 56 industry peers in the Life Sciences Tools & Services industry. HYFT may be in some trouble as it scores bad on both profitability and health. HYFT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year HYFT has reported negative net income.
HYFT had a negative operating cash flow in the past year.
In the past 5 years HYFT always reported negative net income.
In the past 5 years HYFT always reported negative operating cash flow.
HYFT Yearly Net Income VS EBIT VS OCF VS FCFHYFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -71.65%, HYFT is doing worse than 89.29% of the companies in the same industry.
HYFT's Return On Equity of -140.74% is on the low side compared to the rest of the industry. HYFT is outperformed by 83.93% of its industry peers.
Industry RankSector Rank
ROA -71.65%
ROE -140.74%
ROIC N/A
ROA(3y)-49.16%
ROA(5y)-35.25%
ROE(3y)-84.68%
ROE(5y)-57.83%
ROIC(3y)N/A
ROIC(5y)N/A
HYFT Yearly ROA, ROE, ROICHYFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 56.74%, HYFT is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Gross Margin of HYFT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for HYFT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y-0.67%
HYFT Yearly Profit, Operating, Gross MarginsHYFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

3

2. Health

2.1 Basic Checks

HYFT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HYFT has more shares outstanding
Compared to 5 years ago, HYFT has more shares outstanding
The debt/assets ratio for HYFT is higher compared to a year ago.
HYFT Yearly Shares OutstandingHYFT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
HYFT Yearly Total Debt VS Total AssetsHYFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

HYFT has an Altman-Z score of -1.03. This is a bad value and indicates that HYFT is not financially healthy and even has some risk of bankruptcy.
HYFT has a worse Altman-Z score (-1.03) than 82.14% of its industry peers.
HYFT has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.16, HYFT is doing good in the industry, outperforming 60.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC10.23%
HYFT Yearly LT Debt VS Equity VS FCFHYFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

HYFT has a Current Ratio of 2.17. This indicates that HYFT is financially healthy and has no problem in meeting its short term obligations.
HYFT has a Current ratio (2.17) which is comparable to the rest of the industry.
A Quick Ratio of 2.14 indicates that HYFT has no problem at all paying its short term obligations.
HYFT has a Quick ratio (2.14) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 2.14
HYFT Yearly Current Assets VS Current LiabilitesHYFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

5

3. Growth

3.1 Past

HYFT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.47%, which is quite impressive.
The Revenue has decreased by -6.95% in the past year.
Measured over the past years, HYFT shows a quite strong growth in Revenue. The Revenue has been growing by 11.77% on average per year.
EPS 1Y (TTM)54.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.33%
Revenue 1Y (TTM)-6.95%
Revenue growth 3Y8.19%
Revenue growth 5Y11.77%
Sales Q2Q%-39.94%

3.2 Future

Based on estimates for the next years, HYFT will show a very strong growth in Earnings Per Share. The EPS will grow by 37.12% on average per year.
HYFT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.53% yearly.
EPS Next Y40.5%
EPS Next 2Y44.98%
EPS Next 3Y37.12%
EPS Next 5YN/A
Revenue Next Year-29.75%
Revenue Next 2Y9.85%
Revenue Next 3Y15.29%
Revenue Next 5Y15.53%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HYFT Yearly Revenue VS EstimatesHYFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M
HYFT Yearly EPS VS EstimatesHYFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HYFT. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 78.49, HYFT can be considered very expensive at the moment.
HYFT's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.04. HYFT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 78.49
HYFT Price Earnings VS Forward Price EarningsHYFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYFT Per share dataHYFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HYFT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as HYFT's earnings are expected to grow with 37.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.98%
EPS Next 3Y37.12%

0

5. Dividend

5.1 Amount

HYFT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MINDWALK HOLDINGS CORP

NASDAQ:HYFT (10/15/2025, 8:00:02 PM)

After market: 1.77 +0.06 (+3.51%)

1.71

-0.09 (-5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)09-15 2025-09-15/bmo
Earnings (Next)12-08 2025-12-08
Inst Owners8.62%
Inst Owner ChangeN/A
Ins Owners1.16%
Ins Owner ChangeN/A
Market Cap78.93M
Analysts82.5
Price Target4.08 (138.6%)
Short Float %1.08%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.06%
Min EPS beat(2)-14.08%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)20.69%
Min EPS beat(4)-14.08%
Max EPS beat(4)87.75%
EPS beat(8)5
Avg EPS beat(8)9%
EPS beat(12)7
Avg EPS beat(12)4.01%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.84%
Min Revenue beat(2)-50.42%
Max Revenue beat(2)-13.26%
Revenue beat(4)0
Avg Revenue beat(4)-19.71%
Min Revenue beat(4)-50.42%
Max Revenue beat(4)-6.74%
Revenue beat(8)2
Avg Revenue beat(8)-12.74%
Revenue beat(12)3
Avg Revenue beat(12)-9.27%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 78.49
P/S 4.95
P/FCF N/A
P/OCF N/A
P/B 5.34
P/tB 5.34
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)0.02
Fwd EY1.27%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.35
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -71.65%
ROE -140.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.74%
FCFM N/A
ROA(3y)-49.16%
ROA(5y)-35.25%
ROE(3y)-84.68%
ROE(5y)-57.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y-0.67%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.53%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 2.14
Altman-Z -1.03
F-Score5
WACC10.23%
ROIC/WACCN/A
Cap/Depr(3y)20.78%
Cap/Depr(5y)25.53%
Cap/Sales(3y)5.4%
Cap/Sales(5y)5.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.33%
EPS Next Y40.5%
EPS Next 2Y44.98%
EPS Next 3Y37.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.95%
Revenue growth 3Y8.19%
Revenue growth 5Y11.77%
Sales Q2Q%-39.94%
Revenue Next Year-29.75%
Revenue Next 2Y9.85%
Revenue Next 3Y15.29%
Revenue Next 5Y15.53%
EBIT growth 1Y19.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.29%
OCF growth 3YN/A
OCF growth 5YN/A